Manipulating the 4-1BB Pathway to Cure HBV  

作　　者：Zhang Chao Wang Fu-Sheng 

机构地区：[1]Department of Infectious Diseases,the Fifth Medical Center of Chinese PLA General Hospital,National Clinical Research Center for Infectious Diseases,Beijing 100039,China

出　　处：《Infectious Diseases & Immunity》2024年第4期156-157,共2页感染性疾病与免疫（英文）

基　　金：supported by the National Key Research and Development Program of China(2022YFA1303600 and 2023YFC2308100);the National Natural Science Foundation of China(82130019).

摘　　要：Chronic Hepatitis B Virus(HBV)infection is a major global health issue leading to liver cirrhosis and hepatocellular carcinoma.Currently available treatments have limited efficacy in completely eradicating the virus.

关 键 词：CIRRHOSIS INFECTION HEPATOCELLULAR 

分 类 号：R512.62[医药卫生—内科学]